This unique report provides information and analysis not available from any other published source, including:
2022 Supplier Sales and Shares by Segment and Test
2022-2027 Volume and Sales Segment Forecasts by Test
Supplier Strategies and SWOT Analysis
Instrumentation Pipeline
Emerging Technologies
Opportunities for New Analyzers and Consumables
Market Challenges and Risks
The report provides test volume and sales forecasts by market segment for the following assays:
CBC, Erythropoietin, Ferritin, Folate, Hemoglobin, Iron, Iron Total Binding Capacity, Iron Unsaturated Binding Capacity, Reticulocytes, Transferrin, Vitamin B12, Vitamin D
Rationale
During the next decade, the anemia diagnostics market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.
